A meta-analysis of poststroke depression risk factors comparing depressive-related factors versus others.


Journal

International psychogeriatrics
ISSN: 1741-203X
Titre abrégé: Int Psychogeriatr
Pays: England
ID NLM: 9007918

Informations de publication

Date de publication:
11 2020
Historique:
pubmed: 6 2 2020
medline: 23 6 2021
entrez: 5 2 2020
Statut: ppublish

Résumé

Poststroke depression (PSD) is a public health issue, affecting one-third of stroke survivors, and is associated with multiple negative consequences. Reviews tried to identify PSD risk factors with discrepant results, highlighting the lack of comparability of the analyzed studies. We carried out a meta-analysis in order to identify clinical risk factors that can predict PSD. PubMed and Web of Science were searched for papers. Only papers with a strictly defined Diagnostic and Statistical Manual of Mental Disorders depression assessment, at least 2 weeks after stroke, were selected. Two authors independently evaluated potentially eligible studies that were identified by our search and independently extracted data using standardized spreadsheets. Analyses were performed using MetaWin®, the role of each variable being given as a risk ratio (RR). Eighteen studies were included in the meta-analysis. Identified risk factors for PSD with RR significantly above 1 were previous history of depression (RR 2.19, confidence interval (CI) 1.52-3.15), disability (RR 2.00, CI 1.58-2.52), previous history of stroke (RR 1.68, CI 1.06-2.66), aphasia (RR 1.47, CI 1.13-1.91), and female gender (RR 1.35, CI 1.14-1.61). Fixed effects model leads to identification of two more risk factors: early depressive symptoms with an RR of 2.32 (CI 1.43-3.79) and tobacco consumption (RR 1.40, CI 1.09-1.81). Time bias was found for alcohol consumption. Sample size was significantly involved to explain the role of "alcohol consumption" and "cognitive impairment." Five items were significantly predictive of PSD. It might be of clinical interest that depressive-related risk factors (such as past depressive episodes) were having the largest impact.

Identifiants

pubmed: 32014074
pii: S1041610219002187
doi: 10.1017/S1041610219002187
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

1331-1344

Commentaires et corrections

Type : CommentIn

Auteurs

Rebecca Perrain (R)

Clinique des Maladies Mentales et de l'Encéphale, Sainte-Anne Hospital, GHU Paris - Psychiatrie & Neurosciences, Paris, France.

Lila Mekaoui (L)

Clinique des Maladies Mentales et de l'Encéphale, Sainte-Anne Hospital, GHU Paris - Psychiatrie & Neurosciences, Paris, France.

David Calvet (D)

Department of Neurology, Sainte-Anne Hospital, GHU Paris - Psychiatrie & Neurosciences, Université Paris-Descartes, DHU Neurovasc Sorbonne Paris Cité, INSERM U1266, Paris, France.

Jean-Louis Mas (JL)

Department of Neurology, Sainte-Anne Hospital, GHU Paris - Psychiatrie & Neurosciences, Université Paris-Descartes, DHU Neurovasc Sorbonne Paris Cité, INSERM U1266, Paris, France.

Philip Gorwood (P)

Clinique des Maladies Mentales et de l'Encéphale, Sainte-Anne Hospital, GHU Paris - Psychiatrie & Neurosciences, Université Paris-Descartes Sorbonne Paris Cité, INSERM U1266, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH